FiltersReset Filters

With box warnings

Without box warnings

Branded

Generic

31 results

amjevita
(adalimumab-atto)
Amgen Inc
Usage: AMJEVITA is indicated for treating various conditions, including rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis in adults and pediatric patients, depending on the specific condition.
cyltezo
(adalimumab-adbm)
Boehringer Ingelheim Pharmaceuticals, Inc.
Usage: CYLTEZO is indicated for treating moderately to severely active rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, chronic plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis in adults and pediatric patients aged 2 and older.
ilaris
(canakinumab)
Novartis Pharmaceuticals Corporation
Usage: ILARIS (canakinumab) is indicated for treating autoinflammatory Periodic Fever Syndromes, including CAPS, TRAPS, HIDS/MKD, and FMF; active Still's Disease in patients 2 years and older; and symptomatic treatment of gout flares in adults when other treatments are unsuitable.
inveltys
(loteprednol etabonate)
ALCON LABORATORIES, INC.
Usage: INVELTYS is a corticosteroid indicated for reducing post-operative inflammation and pain after ocular surgery.
kevzara
(sarilumab)
sanofi-aventis U.S. LLC
Usage: KEVZARA is indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis and polymyalgia rheumatica who have had inadequate responses to DMARDs or corticosteroids. It is also indicated for active polyarticular juvenile idiopathic arthritis in patients weighing 63 kg or more.
krystexxa
(pegloticase)
Horizon Therapeutics USA, Inc.
Usage: KRYSTEXXA (pegloticase) is indicated for treating chronic gout in adult patients who are refractory to conventional therapy, meaning they have not achieved normalized serum uric acid levels or adequately controlled symptoms with maximum doses of xanthine oxidase inhibitors. It is not recommended for asymptomatic hyperuricemia.
lotemax sm
(loteprednol etabonate)
Bausch & Lomb Incorporated
Usage: LOTEMAX® SM (loteprednol etabonate ophthalmic gel) 0.38% is indicated for the treatment of post-operative inflammation and pain after ocular surgery.
lupkynis
(Voclosporin)
Aurinia Pharma U.S., Inc.
Usage: LUPKYNIS is indicated for the treatment of adult patients with active lupus nephritis (LN) in combination with a background immunosuppressive therapy. Its safety and efficacy have not been established with cyclophosphamide, and its use in this context is not recommended.
lyrica
(PREGABALIN)
Parke-Davis Div of Pfizer Inc
Usage: LYRICA is indicated for managing neuropathic pain related to diabetic peripheral neuropathy and spinal cord injury, postherpetic neuralgia, fibromyalgia, and as adjunctive therapy for partial-onset seizures in patients aged 1 month and older.
naprelan
(Naproxen Sodium)
ALMATICA PHARMA INC.
Usage: NAPRELAN Tablets are indicated for treating rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, tendinitis, bursitis, acute gout, primary dysmenorrhea, and for the relief of mild to moderate pain.

Musculoskeletal (Rheum/Ortho) drugs

amjevita

cyltezo

ilaris

inveltys

kevzara

krystexxa

lotemax sm

lupkynis

lyrica

naprelan